eISSN: 1897-4309
ISSN: 1428-2526
Contemporary Oncology/Współczesna Onkologia
Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
4/2004
vol. 8
 
Share:
Share:
abstract:

Guidelines for kidney cancer Part II: Assessment of renal cell cancer staging. Therapy

Cezary Szczylik
,
Jakub Żołnierek
,
Paweł Nurzyński

Współcz Onkol (2004) vol. 8: 4 (189-199)
Online publish date: 2004/06/03
View full text Get citation
 
In the case of renal cell cancer diagnosis the treatment is controversial. Many scientists claim that only surgery is the effective method of therapy. This article reviews proposed predictive and prognostic factors. It also discusses most common mutations of individual renal cancer types and pathological and clinical data which can have an influence on further diagnostic and therapeutic decisions. Factors which repeat in various classifications are the general status, levels of hemoglobin, calcium and lactate dehydrogenase. They make it possible to predict the patient's further condition and choose optimum therapy. The role of lung and bone metastases resection is undisputed. Systemic therapy of renal cell cancer is controversial. There is no convincing evidence that radiotherapy, chemotherapy or hormonotherapy is effective in the adjuvant treatment. Radiotherapy is a good choice in the case of bone and brain metastases treatment. Only immunotherapy was a breakthrough. Chemoimmunotherapy (interleukin-2, interferon, VBL, 5-fluorouracil) is the only effective therapy for metastatic renal cell cancer. New medicines such as Bay 43-9006, Bevacizumab, CCI-779 give hope for increasing the efficacy of the applied therapy.
keywords:

renal cell cancer, prognostic factors, therapy

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.